
|
-----------------------------------------------------------------------------------------------------------------------------
Vous souhaitez publier une annonce pour un colloque ou une offre d'emploi ?
Transmettez votre demande à cette adresse.
Vous découvrez cette lettre d'information et souhaitez vous y abonner ?
Cliquez sur ce lien.
-----------------------------------------------------------------------------------------------------------------------------
|
|
|
|
Appels à projets ou à candidatures |
|
|
Ruban Rose - AAP : Prix 2025 |
|
Derniers jours pour candidater
L'association Ruban Rose lance son 22e appel à projets de recherche dédiés à la lutte contre le cancer du sein, dans les catégories suivantes :
- Grand Prix Ruban Rose de la Recherche,
- Prix Ruban Rose Avenir,
- Prix Ruban Rose Qualité de Vie.
Date limite de candidature : 30 avril 2025.
Consulter l'AAP.
Plus d'infos.
|
|
Inserm - AAC : Contrats d'interface hospitaliers |
|
Ces contrats d’interface sont destinés à des médecins, pharmaciens ou odontologistes hospitaliers pour leur permettre de se consacrer à la recherche dans des structures mixtes de recherche de l’Inserm. Ils constituent un outil de la politique de l'Inserm permettant de renforcer les liens entre la recherche fondamentale, la recherche clinique et la recherche en santé publique.
Date limite de candidature : 26 mai 2025 à 17h.
Consulter l'AAC.
Plus d'infos.
|
|
|
|
|
EU/IHI - Webinar: Impact on Cancer |
|
May 19th 2025, 10:30-12:00 UTC, online
Innovative Health Initiative, the partnership for health research and innovation between the EU and Europe’s life science industries, will organise the event "Impact on cancer, How IHI and IMI projects are tackling cancer". The webinar will explore some of the highlights from several IHI and former IMI projects focused on cancer:
- PIONEER used big data to address key knowledge gaps related to the screening, diagnosis and treatment of prostate cancer patients.
- OPTIMA is harnessing the power of AI to advance treatments and facilitate decision-making for physicians and patients with prostate, breast and lung cancer.
- CANCER-ID advanced the science that will lead to more widespread use of liquid biopsy (a blood test that detects signs of cancerous tumors, including tumor cells and cancer cell DNA in the blood) in clinical trials of cancer drugs, and in the clinical treatment of patients with cancer.
- GUIDE-MRD is exploring how blood tests could be used to identify which patients might benefit from additional treatment, and which patients would likely not benefit from treatment.
- IMAGIO, a new IHI project that focuses on ‘interventional oncology’, which uses miniaturised instruments to target cancer cells more precisely, thereby sparing health cells.
Registration.
More information.
|
|
EACR/OECI - Conference: Patient Involvement in Cancer Research |
|
October 28th 2025, Virtual
This virtual event, a collaboration between the European Association for Cancer Research and the Organisation of European Cancer Institutes, will explore how meaningful involvement of cancer advocates throughout the research process can lead to impactful cancer research. The following topics will be covered:
- From Bench to Community: Building bridges between science and cancer research through education and public engagement.
- Breaking Barriers: Addressing the challenges of patient/researcher successful involvement in cancer research.
- Driving Progress Together: How researchers, clinicians, and patient advocates can accelerate advances in cancer research.
Deadline for registration: September 29th 2025.
Programme.
More information.
|
|
|
|
|
Institut Pasteur - MOOC: Viruses & Human Cancers |
|
May 6th 2025 - May 5th 2026, online
This MOOC offers a broad overview of the state of knowledge on viruses associated with cancer, the different mechanisms of carcinogenesis, the host immune response and progress in preventing tumors, with the following plan:
- Mechanisms of virus induced oncogenesis: direct,
- Mechanisms of virus induced oncogenesis: indirect,
- Retroviruses,
- Papillomaviruses,
- Hepatitis B and C viruses and hepatocarcinoma,
- Herpes viruses.
Registration and More information.
|
|
|
|
|
Appels à projets ou à candidatures |
|
|
Fondation ARC - AAP : Soutien aux manifestations scientifiques |
|
Dans le cadre de sa mission d’information sur les avancées de la recherche en cancérologie, la Fondation ARC soutient financièrement des manifestations scientifiques en lien avec la recherche en cancérologie.
Date limite de candidature : 19 mai 2025 à midi.
Consulter l'AAP.
Plus d'infos.
|
|
FRM - AAC : Aides individuelles 2025 |
|
Dans le cadre du programme généraliste "Espoirs de la recherche", la Fondation pour la recherche médicale lance son appel à candidatures "Aides individuelles" pour l'année 2025.
Consulter l'AAC.
Aide au retour en France
Date limite de candidature : 22 mai 2024.
Post-doctorat en France
Date limite de candidature : 22 mai 2024.
Plus d'infos.
|
|
|
L’objectif principal de cet appel à projets, lancé par l'Agence nationale de la recherche dans le cadre du PEPR exploratoire "Organes et organoïdes sur puce (O&OoC)", est de faire émerger de nouveaux concepts et technologies et fédérer une communauté élargie souhaitant s’impliquer dans le développement de la 2e génération d’O&OoC, autour de 3 axes :
- O&OoC dérivés de cellules de patients pour réaliser des « jumeaux cliniques » pour la médecine personnalisée,
- O&OoC multifonctionnels ou multiorganes pour mieux comprendre, mimer la physiopathologie humaine et soigner les maladies systémiques ou interorganes,
- O&OoC intégrant des technologies de capteurs et/ou actuateurs multiples ou multiparamétriques pour un suivi des processus biologiques normaux et pathologiques.
Date limite de candidature : 27 mai 2025 à 11h.
Consulter l'AAP.
Plus d'infos.
|
|
Inserm - AAP : Cancérologie pédiatrique (CTCP) |
|
L'Inserm lance l'appel à projets "Conséquences à long terme des traitements en cancérologie pédiatrique", porté par l'Institut thématique Santé publique. Cet appel qui vise à soutenir des recherches pluridisciplinaires ayant pour objectif d’améliorer la compréhension des séquelles à long terme associés aux traitements des cancers pédiatriques. Les projets devront s’appuyer sur des cohortes ou registres populationnels existants.
Date limite de candidature : 28 mai 2025 à midi.
Consulter l'AAP.
|
|
Fonds Villa M - AAC : Bourses de recherche |
|
Le Fonds de dotation Villa M attribue des bourses de recherche à des internes, chefs de clinique ou jeunes praticiens et chercheurs en santé.
Date limite de candidature : 15 juin 2025 à minuit.
Consulter l'AAC.
Plus d'infos.
|
|
|
Save the date
La Ligue nationale contre le cancer accorde des allocations doctorales de 3 ans pour des étudiants s’inscrivant en 2025 en 1re année de thèse au sein d’une université française.
Date limite de candidature (ouverture le 7 mai 2025) : 16 juin 2025.
Consulter l'AAC.
|
|
Fondation ARC - AAP : Pancréas 2025 |
|
L’objectif de cet appel à projets de la Fondation ARC est d’améliorer la compréhension du stroma pancréatique tumoral (matrice extracellulaire, cellules endothéliales, cellules immunitaires et fibroblastes associés au cancer, nerfs innervant le pancréas), et de développer de nouveaux traitements dans le cancer du pancréas.
Date limite de candidature : 16 juin 2025 à 14h.
Consulter l'AAP.
Plus d'infos.
|
|
Fondation ARC - AAC : Passerelle 2025 |
|
La Fondation ARC offre un soutien à de jeunes chercheurs en cancérologie se préparant à présenter les concours des EPST.
Date limite de candidature : 16 juin 2025 à 15h.
Consulter l'AAC.
Plus d'infos.
|
|
NCI/CRUK - Call: Cancer Grand Challenges 2025 |
|
Cancer Grand Challenges is a global initiative that identifies the toughest challenges in cancer research. As partners in this initiative, the US National Cancer Institute and Cancer Research UK invite researchers from across the globe to form new, interdisciplinary and international teams and submit a short Expression of Interest to take on one of the 7 following challenges:
- AI-human collaboration in cancer: develop interdisciplinary AI agents that can generate novel cancer research hypotheses and design research plans for them to be experimentally validated;
- Cancer avoidance: understand the mechanisms by which certain high-risk populations or the extremely aged are resistant to developing cancer;
- The dark proteom: understand and exploit the dark proteome for cancer therapy;
- Mechanisms driving mutational signatures: identify the insults responsible for unexplained mutational signatures;
- The nervous system and cancer: understand the dynamic interactions between the nervous system and cancer;
- Rewiring cancer cells: develop and apply novel ways to rewire cancer cells to their disadvantage;
- Tumour microenvironment dynamics: develop methods to identify the functional role of the tumour microenvironment over time.
Deadline for Expression of Interest submission: June 18th 2025.
See the EOIs Guidelines.
More information.
|
|
Ligue - AAC : Mobilité cliniciens 2025 |
|
Save the date
La Ligue nationale contre le cancer accorde une allocation de mobilité, pour financer un séjour à l’étranger d’une durée d’un ou deux ans, à un clinicien souhaitant poursuivre son activité dans la recherche sur les cancers.
Date limite de candidature 2e session (ouverture le 19 mai 2025) : 19 juin 2025.
Consulter l'AAC.
|
|
EC - CFP: MSCA Cofund 2025 |
|
The objective of the Marie-Sklodovska-Curie Action Cofund Call for proposals is to provide complementary funding for doctoral or postdoctoral programmes managed by entities established in EU Member States or Horizon Europe Associated Countries.
Deadline for application: June 24th 2025, 17:00 Brussels Time.
More information.
|
|
Inserm - AAC : Chaires (CPJ) 2025 |
|
L'Inserm ouvre 10 nouvelles chaires et en réouvre 3 autres sur des thématiques variées : neurosciences, immunologie, bio-informatique, bio-ingénierie, biothérapie, santé publique, cancérologie, etc. Prévue dans la loi de programmation de la recherche, cette nouvelle voie de recrutement sur projet de recherche et d’enseignement vise à répondre à des besoins spécifiques de recherche et d'enseignement et favoriser l‘attractivité internationale de l’Institut.Trois chaires sont dans le domaine de la cancérologie :
Date limite de candidature : 2 septembre 2025 à 17h.
Consulter l'AAP.
Plus d'infos.
|
|
Ligue - AAP : Colloques 2025 |
|
Save the date
La Ligue nationale contre le cancer apporte son soutien à l'organisation de colloques.
Date limite de candidature 2e session (ouverture le 12 mai 2025) : 4 septembre 2025.
Consulter l'AAP.
|
|
|
Le programme Montage de réseaux scientifiques européens ou internationaux de l'Agence nationale de la recherche aide à financer des projets de réseaux, coordonnés par des laboratoires français, permettant d'aboutir à l’élaboration et à la rédaction d’un projet de recherche déposé à un appel à projets européen ou international.
Date limite de candidature (2e session) : 15 septembre 2025 à 13h.
Consulter l'AAP.
Plus d'infos.
|
|
EC - CFP: ERC Proof of Concept 2025 |
|
The ERC Proof of Concept Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research and are therefore available only to Principal Investigators whose proposals draw substantially on their ERC funded research.
Deadline for application: September 18th 2025, 17:00 Brussels Time.
More information.
|
|
|
L’objectif de ce programme de l'Agence nationale de la recherche est d’inciter les acteurs de la recherche académique à créer des partenariats structurés à travers la coconstruction de "laboratoires communs" entre une PME, une ETI ou une start up et un laboratoire d’organisme de recherche.
Dates limites de candidature : 22 septembre 2025, à 17h.
Consulter l'AAP.
Plus d'infos.
|
|
|
Le programme "Soutien aux réseaux scientifiques européens ou internationaux" a été créé par l'Agence nationale de la recherche pour donner les moyens aux scientifiques travaillant dans des laboratoires français ayant déposé en tant que coordinatrice/coordinateur un projet de recherche à des appels collaboratifs européens (Horizon Europe) ou internationaux de renforcer la qualité de leur candidature (proposition complète ou audition) pour la seconde étape de l’appel visé.
Dépôt des candidatures au fil de l'eau.
Consulter l'AAP.
Plus d'infos.
|
|
Inserm - AAP : Programme "Impact Santé" |
|
Le programme Impact Santé, confié à l'Inserm par l'État, a pour objectif de soutenir le développement de solutions pour faire face aux grands défis scientifiques, technologiques et sociétaux dans le domaine de la santé humaine. Les projets "d'amorçage" ou "d'accélération" contribueront notamment :
- à l’ouverture d’un nouveau champ de recherche ;
- à l’essor d’applications ou d’outils s'appliquant à toute la communauté scientifique ;
- au développement de nouveaux produits de santé ou dispositifs médicaux ;
- à une amélioration du système de santé pour les patients, les soignants, ou du parcours de soin global ;
- à une meilleure coordination entre la médecine de ville et l’hôpital.
Voir la présentation du programme.
Dépôt des candidatures au fil de l'eau.
Sélection des projets : mi-juillet, mi-octobre, mi-décembre.
Plus d'infos.
|
|
|
|
|
France génomique/CNRS/Inserm - Symposium: Human Genomics |
|
May 5th - 7th 2025, Paris
This International symposium on Human Genomics will be the opportunity to promote research in genetics and genomics in France and to bring the community together, around the following themes:
- Genetics and Pathologies,
- Population Genetics and Statistical Genetics,
- Genome Annotation,
- Openness to Society/Science Communication,
- Epigenetics / Regulome,
- Immunogenetics,
- Single Cell/Spatial Transcriptomics.
Programme.
More information.
|
|
MATWIN - Convention : MEET2WIN |
|
6 & 7 mai 2025, Bordeaux
La plateforme de soutien à l’innovation en cancérologie MATWIN, filiale d’Unicancer, organise la 10e édition de MEET2WIN, Convention Partnering européenne centrée autour de l’innovation en oncologie.
Inscription et plus d'infos.
|
|
EACR - Conference: Defence is the Best Attack |
|
May 13th - 15th 2025, Barcelona (Spain)
This European Association for Cancer Research conference "Defence is the Best Attack: Immuno-Oncology Breakthroughs" will provide an overview of the most recent advances in the field of immunotherapy from the basic science to clinical studies, including the identification of novel targets. The following topics will be covered:
- Immune checkpoints,
- Innate immune response,
- Microbioma,
- Immune cell therapies,
- Vaccines,
- Biomarkers of response to immunotherapy,
- Mechanisms of resistance to immunotherapy.
More information.
|
|
Institut Cochin - Rencontres clinicobiologiques : diagnostic des sarcomes |
|
14 mai 2025, Paris
Afin de renforcer les liens entre l’Hôpital et l’Institut Cochin, ainsi que l'interface entre recherche clinique et recherche fondamentale, l'Institut Cochin organise des rencontres entre l'Institut et l'hôpital, la rencontre clinicobiologique 2025 étant consacrée au diagnostic des sarcomes à l'ère de la médecine personnalisée.
Programme.
Inscription et plus d'infos.
|
|
Inserm - Rendez-vous Lorier : les Français et l'expérimentation animale |
|
20 mai 2025, 11:00-12:00, en ligne
L'organisation pour une recherche Inserm éthique et responsable accueillera Ivan Balansard, vétérinaire référent modèles animaux du CNRS, président du Gircor, association d’organismes de recherche dont l’objectif est d’informer sur l’utilisation d’animaux et de méthodes alternatives en recherche biologique et médicale. Il présentera la perception sociale de l’expérimentation animale et les enjeux considérables que cette question peut avoir sur la santé de demain.
Inscription et plus d'infos.
|
|
Diverse - Conference: Gamma Delta T Cell |
|
May 20th - 23rd 2025, Toronto (Canada)
The 11th International γδ T Cell Conference will address the following themes:
- Cancer responses,
- Cancer therapies,
- Development & Differentiation,
- Infection responses,
- Ligands & Repertoires,
- Tissues & Inflammation.
Deadline for registration: May 15th 2025.
More information.
|
|
Centre Léon-Bérard/CRCL/Cancéropôle CLARA - Colloque : L'insoutenabilité en cancérologie |
|
|
EC - Webinar: Horizon Europe Info Days/Cluster 1 |
|
May 22nd 2025, 09:00 CET
This info day aims to inform (potential) applicants about the topics included in the Cluster 1 'Health' work programme of 2025.
More information.
|
|
EC - Webinar: Horizon Europe Info Days/EU Missions |
|
May 23rd 2025, 09:30-11:30 CET
This event aims to inform potential applicants about the new topics included in the EU Cancer Mission work programme 2025
More information.
|
|
EACR - Annual Congress 2025: Innovative Cancer Science |
|
June 16th - 19th 2025, Lisbon (Portugal)
The 2025 Annual Congress of the European Association for Cancer Research is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.
Deadline for registration: May 27th 2025.
More information.
|
|
Le Studium IAS - Conference: Ion Channel Signalling in Health & Disease |
|
|
Inserm - Symposium: Extracellular Vesicles 2025 |
|
June 25th - 27th 2025, Paris
The Inserm’s Thematic Institutes Cell Biology, Reproduction, Development and Evolution (BCRDE), Health Technologies (TS), Immunology, Inflammation, Infectiology and Microbiology (I3M) and the French Society of Extravellular Vesicles (FSEV) organise a meeting which will focus on:
- Recent advances in understanding the biology and function of EVs;
- Cutting-edge developments in the detection, isolation, and characterization of EVs for disease research, including their engineering and therapeutic applications.
Registration (free but mandatory).
Programme.
More information.
|
|
INCa/NCC - Conference: Poor Prognosis Cancers |
|
|
EMBO - Workshop: Phosphatases |
|
July 27th - 31st 2025, Würzburg (Germany)
This European Molecular Biology Organisation workshop "Phosphatases: From Basic Research to Translation" will address topics such as phosphatase-driven disease biology, phosphatase structure, function and regulation, drug discovery and translation to the clinic, with a session dedicated to cancer research.
Programme & More information.
|
|
EMBO - Workshop: SUMOylation |
|
September 22nd - 25th 2025, La Grande Motte
The aim of this European Molecular Biology Organisation workshop "SUMOylation: From Discovery to Translation" is to integrate perspectives on the function of SUMOylation from different fields, including oncology and drug discovery.
Deadline for abstract submission: May 1st 2025.
Deadline for registration: June 1st 2025.
Programme & More Information.
|
|
EACR - Conference: Goodbye Flat Biology |
|
September 23rd - 25th 2025, Essen (Germany)
This European Association for Cancer Research conference will focus on cancer models that span in vitro investigations to in vivo cancer biology. Emerging topics include how the extracellular matrix controls cell architecture, mechanobiology, the immune response, and how cell fate transitions underpin tissue morphogenesis and the metastatic cascade. will bring together international leaders of this field to identify the most relevant current insights, and to develop a roadmap for future preclinical, translational and clinical research.The following topics will be covered:
- How complex cell interactions are coordinated to control tumour growth and metastasis, including cell fate transitions in tissue biology and cancer,
- Targetable roles of the extracellular matrix in cancer biology,
- Cancer immunotherapies,
- Advanced imaging technologies,
- Organoids and microtissue platforms,
- Spatial transcriptomics.
Deadline for abstract submission: June 23rd 2025.
Deadline for registration: August 26th 2025.
Programme.
More information.
|
|
CGO - Workshop: Tumour Targeting, Imaging, Radiotherapies |
|
September 24th - 27th 2025, Erquy
The "Tumour Targeting, Imaging, Radiotherapies" network of the Cancéropôle Grand-Ouest organises its 18th international workshop. The focus will be on poor prognosis cancers, which remain a major priority for cancer research. The workshop will highlight how combination treatments and therapeutic associations open up new perspectives. Particular attention will also be given to innovative technologies: Artificial Intelligence to improve radiotherapy dosimetry, the development of new biological targets, and key topics in external beam radiotherapy such as high-dose-rate radiotherapy.
Deadline for abstract submission: May 26th 2025.
Deadline for registration: June 27th 2025.
Programme.
More information.
|
|
HSLB - Meeting: Liquid biopsy, from bench to bedside |
|
September 24th - 27th 2025, Thessaloniki (Greece)
The Hellenic Society of Liquid Biopsy organises its 7th Advances in Circulating Tumor Cells (ACTC) entitled "Liquid Biopsy: From Bench to Bedside". The meeting will focus on the latest advances on liquid biopsy basic research, state of the art technologies, and clinical applications in many types of cancer, from bench to bedside.
Deadline for early registration: July 31st 2025.
Programme and More information.
|
|
Diverse - Symposium: Metabolism & Cancer |
|
October 8th - 10th 2025, La Grande-Motte
This 6th Metabolism & Cancer Symposium will address the following themes:
- Host Metabolic Reprogramming,
- Stem Cells and Metabolism,
- Metabolism-driven Epigenetics/Epitranscriptomics
- Metabolic Control of Drug Resistance, Therapy and Biomarkers.
Deadline for early bird registration: September 8th 2025.
More information.
|
|
TOR Science Club - Conference: The TOR de France 2025 |
|
Save the date
October 9th - 10th 2025, Nice
Currently "TOR de France" is a unique conference series in the world entirely devoted to the fields of "Target Of Rapamycin" signaling, nutrition, growth, metabolism, development. The pluridiplinary approach of the conference allows new and fruitful feedbacks on everyone's work and have proven to foster innovative collaborations.
Preliminary Programme & More information.
|
|
EACR - Conference: Cancer Neuroscience |
|
October 14th - 16th 2025, Bilbao (Spain)
The bidirectional crosstalk between both the central and peripheral nervous system and cancer has changed the understanding of malignant diseases throughout the body. This European Association for Cancer Research conference will bring together international leaders of this field to identify the most relevant current insights, and to develop a roadmap for future preclinical, translational and clinical research.The following topics will be covered:
- Neural influences on cancer cells,
- Neural influences on the tumor environment,
- Influences of cancer (therapies) on the nervous system,
- Cancer-intrinsic neural mechanisms.
Deadline for abstract submission: June 30th 2025.
Deadline for registration: September 15th 2025.
Programme.
More information.
|
|
UCBL/Spatial-Cell-ID - Workshop: AI/ML for single-cell spatial transcriptomics |
|
|
EMBO/EMBL - Symposium: Organoids - Modelling Organ Development and Disease in 3D |
|
October 22nd - October 25th 2025, Heidelberg (Germany) & Virtual
The aim of this 5th edition of the European Molecular Biology Organisation/European Molecular Biology Laboratory symposium on organoids is to incorporate more complementary technologies, such as multiomics, engineered embryo models and bioengineering, as well as to increase the representation of the topic of cancer, with the following sessions:
- Concepts from development and evolution,
- Building organoid complexity,
- Organoids from adult stem cells,
- Organoids in regenerative medicine/therapy,
- Organoids in disease modeling,
- Organoids and engineering.
Deadline for abstract submission: July 16th 2025.
Deadlines for registration: September 10th 2025 (on-site attending) & October 15th 2025 (virtual attending).
More information.
|
|
EACR/Mark Foundation - Joint Conference: Early-Onset Cancers |
|
November 11th - 13rd 2025, Bergamo (Italy)
The conference "EACR-Mark Foundation Joint Conference: The Rise of Early-Onset Cancers - Biology, Causes, and Detection", organised by the European Association for Cancer Research, will address the following themes:
- Systems and translational cancer epidemiology,
- Molecular pathological epidemiology,
- Risk factors in early life and young adulthood,
- Precision-based cancer prevention/control strategies,
- Screening, early symptoms and early detection,
- Biological basis for cancer disparity,
- Aetiology of sporadic cancers among younger adults,
- Molecular features of early-onset cancers,
- Exposome changes from the millennials to contemporary young generations (including diet, lifestyle, obesity, environment and the microbiome),
- Interactive roles of environment (i.e. the exposome), microbiome, immunity, and tumour in carcinogenesis,
- Interaction between carcinogens and genetic, polygenic, or epigenetic predispositions,
- Preclinical experimental models of early-onset cancers,
- Microsimulation modelling,
- Treatment, including impact on quality of life and survivorship.
Deadline for abstract submission: September 15th 2025.
Deadline for registration: October 13th 2025.
Programme.
More information.
|
|
EACR - Conference: Cancer Cell Plasticity |
|
December 2th - 3rd 2025, Virtual
The European Association for Cancer Research conference "Cancer Cell Plasticity: Cracking the Code of Adaptation and Survival" will explore the fundamental mechanisms that control cancer cell plasticity at multiple biological levels, including the epigenome, transcriptome, metabolome, and cellular microenvironment. Experts will also discuss innovative approaches to target cancer cell plasticity using novel pharmacological interventions, aiming to prevent or reverse the adaptive mechanisms cancer cells use to circumvent conventional therapies. The following topics will be covered:
- Cancer cell plasticity
- Metastasis
- Therapy resistance
- Tumour heterogeneity
- Non-genetic adaptations in cancer cells
- Tumour-microenvironment interactions
- Therapy resistance
Deadline for abstract submission: October 6th 2025.
Deadline for registration: November 3rd 2025.
Programme.
More information.
|
|
|
|
|
Institut Curie/PSL - Course: Radiomics |
|
|
Institut Curie/PSL - Course: Post-transcritional Gene Regulation |
|
May 12th - 16th 2025, Orsay & Paris
The aim of the international course "Post-transcriptional Gene Regulation", organised by the Institut Curie/PSL University Training office, is to provide an overview of post transcriptional gene regulations at multiple levels, including (pre-)messenger RNA splicing, polyadenylation, modifications (epitranscriptome), localization, translation and degradation.
Programme.
More information.
|
|
Institut Curie/PSL - Course: Genome Instability and Human Disease |
|
May 19th - 23rd 2025, Paris
The international course "Genome Instability and Human Disease", organised by the Institut Curie/PSL University Training office, will address the following topics:
- Basics mechanisms for maintaining genome stability (repair, replication, DNA damage signaling, spatial genome organization);
- Dysfunction of these pathways in human diseases (cancer, aging, immunodeficiency);
- Molecular signature of genome instability;
- The DNA damage response as anti-cancer therapeutic targets and tools for diagnostic/prognostic.
More information.
|
|
EMBO - Course: Imaging-based Spatial-omics |
|
June 15th - 20th 2025, Heidelberg (Germany)
This course organised by the European Molecular Biology Organisation will provide participants a comprehensive introduction to the various methods of spatial-omics and in particular those of multiplex immunofluorescence and spatial transcriptomics.The following topics will be covered:
- Tissue sample preparation,
- In situ sequencing,
- Oligo probe design,
- In situ signal amplification,
- Antibody-DNA conjugation,
- Multiplexed protein imaging (IBEX and Immuno-SABER),
- Basic data processing and analysis.
More information.
|
|
EMBO - Course: Advanced Methods in Bioimage Analysis |
|
September 14th - 19th 2025, Heidelberg (Germany) & Virtual
This course organised by the European Molecular Biology Organisation will concentrate on teaching cutting-edge concepts and tools for quantitative image analysis and will seek to upgrade the competencies of future bioimage analysis experts on both theoretical algorithm advancements as well as on practical implementation skills. The following topics will be covered:
- Image analysis workflow and data management,
- Using AI and natural language processing for image analysis,
- Cells and particles tracking,
- Spatial statistics and omics integration,
- Deep learning for bioimage analysis,
- Image-based behaviour modeling,
- Spatial modeling and shape analysis,
- Open science, reproducible research and women in science.
Deadline for application: June 4th 2025.
Programme.
More information.
|
|
Institut Curie/PSL - Course: Computational Systems Biology of Cancer |
|
September 22nd - 26th 2025, Paris
The Institut Curie/PSL University Training office organises the 8th edition of the international course "Computational Systems Biology of Cancer", dedicated to "Multimodal data analysis and network modelling to master cancer hallmarks".
Deadline for registration: June 15th 2025.
More information.
|
|
EMBO - Course: Targeted proteomics |
|
October 5th - 10th 2025, Barcelona (Spain)
The practical course "Targeted proteomics: Advanced tools for biomedical research", organised by the European Molecular Biology Organisation, will give the participants the necessary know-how to implement the targeted proteomics workflows in their own research laboratories.
Deadline for application: May 15th 2025.
Programme and more information.
|
|
Cancéropôle IdF - Cours : MOOC NGS & Cancer |
|
Le Cancéropôle Île-de-France met à disposition des chercheurs académiques franciliens, impliqués dans des projets de recherche en cancérologie, le MOOC RNASeq Bulk, proposé en libre accès durant toute l’année 2025. Cette formation en ligne a pour objectif d'initier à l’analyse de données RNA-seq de type bulk avec R Studio, en prenant l’exemple de l’analyse de l’expression différentielle de gènes.
Inscription.
Programme.
Plus d'infos.
|
|
Sorbonne Université - DU : Biopsies liquides : de la biologie à la clinique |
|
Année 2024-2025
La faculté de santé/Sorbonne Université lance la première formation universitaire française consacrée aux biopsies liquides, avec les objectifs suivants :
- consolider les connaissances sur les principales étapes de la tumorigenèse et de la dissémination métastatique ;
- développer le concept de biopsie liquide : avantages et limites ;
- exposer les différents composants de la biopsie liquide (ADN tumoral circulant, cellules tumorales circulantes, vésicules extracellulaires circulantes) ;
- expliciter la pertinence clinique de chaque biomarqueur circulant pour une médecine personnalisée proposée à des patients atteints d’un cancer solide ;
- détailler les technologies d’isolement et de caractérisation des différents marqueurs et se familiariser avec les outils d’analyse dont la bioinformatique et l’Intelligence artificielle.
Procédure et inscription.
Programme.
Plus d'infos.
|
|
|
|
|
UMR 9196 - Post-doctorat en viro-oncologie |
|
|
CRCL - Ingénieur de recherche chef de projet |
|
Le pôle de psychologie/santé publique du département Sciences humaines et sociales du Centre de recherche en cancérologie de Lyon recrute un chef de projet/Ingénieur de recherche, qui aura pour mission de participer à la conception, à la coordination et à la mise en œuvre de projets scientifiques/cliniques, ainsi qu’au recueil, à l’analyse des données et à leur valorisation.
Date de début souhaitée : février 2025.
Consulter l'AAC.
|
|
AMMICa - Head of Core Facility |
|
The AMMICa (Molecular Analysis, Modeling and Imaging of Cancer) unit (Gustave-Roussy/Paris-Saclay University/CNRS/Inserm) is seeking a Head for its Rare Circulating Cells Core Facility.
See the Call.
|
|
UMR 7369 - Post-Doc Position on Glioblastoma |
|
A fully funded postdoctoral position supported by ITMO Cancer-Aviesan (PCSI Programme) is available in the MEDyC (Matrice extracellulaire et dynamique cellulaire, Université Reims Champagne-Ardenne/CNRS 7369) research unit.
See the Call.
|
|
Inserm U1109 - Post-Doc Position |
|
|
LabEx TOUCAN/IPBS - Post-Doc Position |
|
|
Télécharger au format PDF |